| Mr Oswald Llanderosos, MD | |
|
1553 N Porter Ave, Norman, OK 73071-6621 | |
| (405) 217-8500 | |
| (405) 217-8501 |
| Full Name | Mr Oswald Llanderosos |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 1553 N Porter Ave, Norman, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679554737 | NPI | - | NPPES |
| 100108050A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 11647 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Oswald Llanderosos, MD 1553 N Porter Ave, Norman, OK 73071-6621 Ph: (405) 217-8500 | Mr Oswald Llanderosos, MD 1553 N Porter Ave, Norman, OK 73071-6621 Ph: (405) 217-8500 |
News Archive
With pubic healthcare systems becoming increasingly strained due to the impact of COVID-19, healthcare professionals are having to question whether to factor age in as a priority when deciding who to treat.
Much of our knowledge of the brain's role in regulating breathing comes from research with mice and rats. A chemical receptor within the brain stem communicates with the central nervous system to generate the basic pattern of breathing. The next step is applying that information to human tissue to identify these critical components in the human brain and their medical implications.
Researchers have discovered a promising alternative to common antibiotics used to fight the bacteria that causes strep throat. In an article published in the Proceedings of the National Academy of Sciences, the scientists discussed how their discovery could fight the infection with a reduced risk of antibiotic resistance.
Oncolytics Biotech Inc. has announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers.
Research conducted at Leiden has established that guts-on-chips respond in the same way to aspirin as real human organs do. This is a sign that these model organs are good predictors of the effect of medical drugs on the human body. Publication in Nature Communications on 15 August.
› Verified 2 days ago
Justin Elliot Fields, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 950 N Porter, Suite 300, Norman, OK 73071 Phone: 405-329-0121 Fax: 405-292-6099 | |
Sunil Thomas Mathew, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3500 Healthplex Pkwy Ste 200, Norman, OK 73072 Phone: 405-515-2222 Fax: 405-515-2208 | |
Aaron Lee Boyd, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 650 24th Ave Sw, Suite 110, Norman, OK 73069 Phone: 405-307-5337 Fax: 405-253-4148 | |
Archana Gautam, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3500 Healthplex Pkwy, Suite 200, Norman, OK 73072 Phone: 405-515-2222 Fax: 405-307-5617 | |
Philip C Bird, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1125 N Porter Ave, Norman, OK 73071 Phone: 405-360-2777 Fax: 405-360-2780 | |
Robert Michael Holbrook, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1515 N Porter Ave, Suite 200, Norman, OK 73071 Phone: 405-366-8619 Fax: 405-366-1839 | |
Katherine Hays, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3500 Healthplex Pkwy Ste 200, Norman, OK 73072 Phone: 405-515-2222 Fax: 405-307-5618 |